| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35561-357-12 | 35561-357 | HUMAN PRESCRIPTION DRUG | CARBAMAZEPINE ER | carbamazepine | TABLET, EXTENDED RELEASE | ORAL | 20211209 | N/A | ANDA | ANDA215591 | AustarPharma LLC | CARBAMAZEPINE | 400 mg/1 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (35561-357-12) |
| 35561-356-12 | 35561-356 | HUMAN PRESCRIPTION DRUG | CARBAMAZEPINE ER | carbamazepine | TABLET, EXTENDED RELEASE | ORAL | 20211209 | N/A | ANDA | ANDA215591 | AustarPharma LLC | CARBAMAZEPINE | 200 mg/1 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (35561-356-12) |
| 35561-355-12 | 35561-355 | HUMAN PRESCRIPTION DRUG | CARBAMAZEPINE ER | carbamazepine | TABLET, EXTENDED RELEASE | ORAL | 20211209 | N/A | ANDA | ANDA215591 | AustarPharma LLC | CARBAMAZEPINE | 100 mg/1 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (35561-355-12) |